Uptake and distribution of fluorescein-labeled D-2 dopamine receptor antisense oligodeoxynucleotide in mouse brain

被引:18
|
作者
Zhang, SP
Zhou, LW
Morabito, M
Lin, RCS
Weiss, B
机构
[1] MED COLL PENN & HAHNEMANN UNIV, DEPT PHARMACOL, PHILADELPHIA, PA 19129 USA
[2] MED COLL PENN & HAHNEMANN UNIV, DEPT ANAT & NEUROBIOL, PHILADELPHIA, PA 19129 USA
关键词
antisense oligonucleotide; phosphorothioate; D2 dopamine receptor;
D O I
10.1007/BF02736845
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To determine the uptake and distribution of oligodeoxynucleotides in brain, a 20-mer phosphorothioated oligodeoxynucleotide complementary to a portion of the D-2 dopamine receptor mRNA was fluorescently labeled with fluorescein isothiocyanate (FITC) and injected into the lateral cerebral ventricles of mice. At various survival times after the injection, the brains were removed, fixed, sectioned, and viewed under a fluorescent microscope. The results showed that the oligodeoxynucleotide was rapidly taken up into the brain. Initially the label was relatively diffusely spread throughout the interstitial spaces of the brain, then became redistributed to the cellular compartments. The signal extended from those forebrain nuclei located immediately in contact with the ventricles, such as the corpus striatum, septum, and hippocampus, to areas further removed from the ventricles, such as the cerebral cortex, nucleus accumbens, and substantia nigra. When the FITC-labeled D, antisense oligodeoxynucleotide was given once daily for 4 d, the signal intensity seen 24 h after the last injection appeared to be of greater intensity overall compared to that seen after a single injection. At early time-points the oligodeoxynucleotide signals appeared to be punctuated and were found in cell bodies as well as in proximal dendritic processes. However, not all cells were equally labeled, suggesting an uneven uptake and accumulation of the D-2 antisense into the various cell types. At later time-points the fluorescent signal appeared granular; at these times the injected material was largely degraded. These studies show that a D-2 dopamine receptor antisense oligodeoxynucleotide is rapidly taken up from cerebral ventricles into brain, becomes widely distributed throughout the brain tissue to areas far removed from direct contact with the ventricles, and appears to accumulate to a different extent in the various brain areas and cell types.
引用
收藏
页码:13 / 28
页数:16
相关论文
共 50 条
  • [1] D-2 DOPAMINE-RECEPTOR ANTISENSE OLIGODEOXYNUCLEOTIDE INHIBITS THE SYNTHESIS OF A FUNCTIONAL POOL OF D-2 DOPAMINE-RECEPTORS
    QIN, ZH
    ZHOU, LW
    ZHANG, SP
    WANG, YM
    WEISS, B
    MOLECULAR PHARMACOLOGY, 1995, 48 (04) : 730 - 737
  • [2] IN-VIVO ADMINISTRATION OF AN OLIGODEOXYNUCLEOTIDE ANTISENSE TO THE D-2 DOPAMINE-RECEPTOR MESSENGER-RNA INHIBITS D-2 DOPAMINE RECEPTOR-MEDIATED BEHAVIOR AND THE EXPRESSION OF D-2 DOPAMINE-RECEPTORS IN MOUSE STRIATUM
    ZHOU, LW
    ZHANG, SP
    QIN, ZH
    WEISS, B
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 268 (02): : 1015 - 1023
  • [3] Intrastriatal administration of an oligodeoxynucleotide antisense to the D-2 dopamine receptor mRNA inhibits D-2 dopamine receptor-mediated behavior and D-2 dopamine receptors in normal mice and in mice lesioned with 6-hydroxydopamine
    Zhou, LW
    Zhang, SP
    Weiss, B
    NEUROCHEMISTRY INTERNATIONAL, 1996, 29 (06) : 583 - 595
  • [4] Expression of a D-2 dopamine receptor antisense RNA in brain inhibits D-2-mediated behaviors
    Weiss, B
    Davidkova, G
    Zhou, LW
    Zhang, SP
    Morabito, M
    NEUROCHEMISTRY INTERNATIONAL, 1997, 31 (04) : 571 - 580
  • [5] D-2 dopamine receptor antisense increases the activity and mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in mouse brain
    Hadjiconstantinou, M
    Neff, NH
    Zhou, LW
    Weiss, B
    NEUROSCIENCE LETTERS, 1996, 217 (2-3) : 105 - 108
  • [6] ANTISENSE OLIGODEOXYNUCLEOTIDE INHIBITS D(2)-DOPAMINE RECEPTOR-MEDIATED BEHAVIOR AND D(2)-MESSENGER RNA
    WEISS, B
    ZHOU, LW
    ZHANG, SP
    QIN, ZH
    NEUROSCIENCE, 1993, 55 (03) : 607 - 612
  • [7] ANTISENSE OLIGODEOXYNUCLEOTIDE REDUCES BRAIN DOPAMINE-D2 RECEPTORS - BEHAVIORAL-CORRELATES
    ZHANG, M
    CREESE, I
    NEUROSCIENCE LETTERS, 1993, 161 (02) : 223 - 226
  • [8] BRAIN DOPAMINE D-2 RECEPTOR MECHANISMS IN SPONTANEOUSLY HYPERTENSIVE RATS
    VANDENBUUSE, M
    JONES, CR
    WAGNER, J
    BRAIN RESEARCH BULLETIN, 1992, 28 (02) : 289 - 297
  • [9] D-2 dopamine receptor polymorphism and brain regional glucose metabolism
    Noble, EP
    Gottschalk, LA
    Fallon, JH
    Ritchie, TL
    Wu, JC
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 74 (02): : 162 - 166
  • [10] ANTISENSE KNOCKOUT OF CNS D-2 DOPAMINE-RECEPTORS
    CREESE, I
    ZHANG, M
    SCHIZOPHRENIA RESEARCH, 1994, 11 (02) : 145 - 145